UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of neurology, ISSN 0340-5354, 2016, Volume 263, Issue 10, pp. 2004 - 2021
Drugs | Neurology | Neurosciences | Medicine & Public Health | Medication | Adverse event | Neuroradiology | Progressive multifocal leukoencephalopathy | Side effect | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroimaging | Leukoencephalopathy, Progressive Multifocal - therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Leukoencephalopathy, Progressive Multifocal - classification | JC Virus - genetics | Humans | Middle Aged | Databases, Factual - statistics & numerical data | Male | Pharmacovigilance | Leukoencephalopathy, Progressive Multifocal - diagnosis | Cerebral Cortex - diagnostic imaging | Netherlands | DNA - cerebrospinal fluid | Natalizumab - therapeutic use | Adult | Female | Aged | Leukoencephalopathy, Progressive Multifocal - cerebrospinal fluid | Immunologic Factors - therapeutic use | Complications and side effects | Leukoencephalopathy, Progressive multifocal | Development and progression | Dosage and administration | Research | Risk factors | Immunosuppressive agents | Index Medicus | Original Communication
Journal Article
Annals of neurology, ISSN 0364-5134, 12/2014, Volume 76, Issue 6, pp. 802 - 812
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Leukoencephalopathy, Progressive Multifocal - chemically induced | Natalizumab | Humans | Risk Factors | JC Virus - metabolism | Biomarkers - blood | Leukoencephalopathy, Progressive Multifocal - blood | Leukoencephalopathy, Progressive Multifocal - diagnosis | Antibodies, Viral - blood | Longitudinal Studies | Drug therapy | Plasma | Index Medicus
Journal Article
Mayo Clinic proceedings, ISSN 0025-6196, 01/2018, Volume 93, Issue 1, pp. 123 - 125
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Leukoencephalopathy, Progressive Multifocal - therapy | Humans | Fatal Outcome | Adult | Cerebrospinal Fluid - virology | Female | Leukoencephalopathy, Progressive Multifocal - diagnosis | Case studies | Care and treatment | Diagnosis | Risk factors | Leukoencephalopathy, Progressive multifocal | Acquired immune deficiency syndrome--AIDS | Leukemia | Leukoencephalopathy | Lymphoma | Deoxyribonucleic acid--DNA | Progressive multifocal leukoencephalopathy | Immune system | Index Medicus | Abridged Index Medicus
Journal Article
Annals of neurology, ISSN 0364-5134, 2014, Volume 76, Issue 6, pp. 792 - 801
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Natalizumab | Multiple Sclerosis - cerebrospinal fluid | Humans | Middle Aged | JC Virus - metabolism | Male | Leukoencephalopathy, Progressive Multifocal - diagnosis | DNA, Viral - cerebrospinal fluid | Young Adult | Leukoencephalopathy, Progressive Multifocal - chemically induced | Adult | Female | Biomarkers - cerebrospinal fluid | Leukoencephalopathy, Progressive Multifocal - cerebrospinal fluid | Antibodies, Viral - cerebrospinal fluid | Multiple Sclerosis - drug therapy | Drug therapy | Medical research | Deoxyribonucleic acid--DNA | Index Medicus | Medicin och hälsovetenskap
Journal Article
Neurology, ISSN 0028-3878, 05/2011, Volume 76, Issue 20, pp. 1697 - 1704
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Predictive Value of Tests | Prognosis | Natalizumab | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Cause of Death | Socioeconomic Factors | Antibodies, Monoclonal, Humanized | Karnofsky Performance Status | Anti-Inflammatory Agents - therapeutic use | Product Surveillance, Postmarketing | Adult | Female | Mitoxantrone - therapeutic use | Disability Evaluation | Treatment Outcome | Leukoencephalopathy, Progressive Multifocal - mortality | Multiple Sclerosis - complications | Magnetic Resonance Imaging | Survival Analysis | Leukoencephalopathy, Progressive Multifocal - etiology | Early Diagnosis | Multiple Sclerosis - drug therapy | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Journal of neuroimmunology, ISSN 0165-5728, 12/2020, Volume 349, pp. 577420 - 577420
ICL | John Cunningham vvirus | Idiopathic CD4+ T cell lymphocytopenia | JCV | PML | Progressive multifocal leukoencephalopathy | Idiopathic CD4 | T cell lymphocytopenia | Neurosciences | Immunology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Diagnosis, Differential | T-Lymphocytopenia, Idiopathic CD4-Positive - diagnostic imaging | Humans | CD4-Positive T-Lymphocytes - metabolism | T-Lymphocytopenia, Idiopathic CD4-Positive - blood | Adult | Male | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Leukoencephalopathy, Progressive Multifocal - blood | Index Medicus
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 03/2019, Volume 90, Issue 3, pp. 261 - 267
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Humans | Middle Aged | Male | Multiple Sclerosis - diagnostic imaging | Young Adult | Magnetic Resonance Imaging | Natalizumab - therapeutic use | Leukoencephalopathy, Progressive Multifocal - etiology | Multiple Sclerosis - pathology | Adult | Female | Italy | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Leukoencephalopathy, Progressive Multifocal - pathology | Retrospective Studies | Early Diagnosis | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy | Neurology | Multiple sclerosis | Nuclear magnetic resonance--NMR | Brain research | Surveillance | Laboratories | Medical diagnosis | Patients | Index Medicus
Journal Article
Lancet neurology, ISSN 1474-4422, 2010, Volume 9, Issue 4, pp. 425 - 437
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Polyomavirus Infections - physiopathology | Leukoencephalopathy, Progressive Multifocal - therapy | Humans | Tumor Virus Infections - diagnosis | Leukoencephalopathy, Progressive Multifocal - diagnosis | Polyomavirus Infections - pathology | Polyomavirus Infections - diagnosis | Tumor Virus Infections - physiopathology | JC Virus | Polyomavirus Infections - therapy | Tumor Virus Infections - therapy | Leukoencephalopathy, Progressive Multifocal - pathology | Leukoencephalopathy, Progressive Multifocal - physiopathology | Tumor Virus Infections - pathology | Highly active antiretroviral therapy | Nervous system diseases | Multiple sclerosis | Psoriasis | Dermatology | Formulae, receipts, prescriptions | Leukoencephalopathy, Progressive multifocal | Monoclonal antibodies | Development and progression | Dermatologic agents | Crohn's disease | HIV (Viruses) | Index Medicus | Brain
Journal Article